PARVB Human shRNA Plasmid Kit (Locus ID 29780)
CAT#: TR310602
PARVB - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 4,790.00
货期*
现货
规格
Cited in 1 publication. |
Product images
经常一起买 (2)
PARVB mouse monoclonal antibody,clone OTI1B7
CNY 1,999.00
CNY 2,700.00
Specifications
Product Data | |
Product Name | PARVB Human shRNA Plasmid Kit (Locus ID 29780) |
Locus ID | 29780 |
UniProt ID | Q9HBI1 |
Synonyms | CGI-56 |
Vector | pRS |
Format | Retroviral plasmids |
Kit Components | PARVB - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector(Gene ID = 29780). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pRS Vector, TR30012, included for free. |
RefSeq | NM_001003828, NM_001243385, NM_001243386, NM_013327, NM_013327.1, NM_013327.2, NM_013327.3, NM_013327.4, NM_001003828.1, NM_001003828.2, NM_001243386.1, NM_001243385.1, BC046103, BC017461, BC039811, NM_013327.5 |
Summary | This gene encodes a member of the parvin family of actin-binding proteins, which play a role in cytoskeleton organization and cell adhesion. These proteins are associated with focal contacts and contain calponin homology domains that bind to actin filaments. This family member binds to alphaPIX and alpha-actinin, and it can inhibit the activity of integrin-linked kinase. This protein also functions in tumor suppression. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Aug 2011] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Citations (1)
The use of this RNAi has been cited in the following citations: |
---|
Expression of parvin-ß is a prognostic factor for patients with urothelial cell carcinoma of the upper urinary tract
,C-F Wu, K-F Ng, C-S Chen, P-L Chang, C-K Chuang, W-H Weng, S-K Liao, S-T Pang,
British Journal of Cancer 103, 852-860 (24 August 2010) doi:10.1038/sj.bjc.6605835 Full Paper
[ParvB]
|
Documents
Product Manuals |
FAQs |
SDS |
Customer
Reviews
Loading...